Moreover, CNN achieved an accuracy of 0.85 in the classification of circulating blood EVs containing various glioblastoma variants (EGFR amplification, EGFRvIII, and MGMT methylation) while also achieving an AUC value of 0.91 in discriminating between patients with GBM with genetic variants and healthy donors. Here, EGFR is linked to glioblastoma.